Antonio Garcia Trinidad

Antonio Garcia Trinidad has a diverse and extensive work experience in the field of biology and drug discovery. Antonio is currently working as a Project Director, Biology at Exscientia, where they lead multiple projects in the areas of oncology and inflammation diseases. Antonio'srole involves utilizing AI to understand drug mechanisms of action and employing data-driven compound progression strategies.

Prior to their current position, Antonio worked at AstraZeneca for several years. Antonio started as a Postdoctoral Research Associate and later held roles as a Senior Research Scientist and Associate Principal Scientist/Science Lead. During their time at AstraZeneca, Antonio made significant contributions to target selection and pre-clinical validation, compound screening strategies, and lead optimization. Antonio also played a leadership role in coordinating scientific activities, managing stakeholders, and mentoring graduate and postdoc researchers.

Before joining AstraZeneca, Antonio gained research experience at various institutes, including the Cancer Research UK Beatson Institute, CNIO - Spanish National Cancer Research Centre, Consejo Superior de Investigaciones Científicas, UC Irvine, University of Dundee, and Universidad de Valladolid. Antonio'sresearch focused on studying intracellular signaling pathways, innate and adaptive immunity, and T-cell signaling in autoimmune diseases.

Antonio's early career also involved research projects related to fertility and reproductive health at the Hospital San Pedro de Alcantara, Unidad de Investigacion, and the Reproductive Fertility Clinic.

Overall, Antonio Garcia Trinidad has built a solid foundation of expertise and has contributed significantly to the field of biology and drug discovery through their diverse work experiences.

Antonio Garcia Trinidad earned a Degree in Molecular and Cellular Biology from Universidad de Extremadura, from 1997 to 2002. Antonio then pursued a Master's degree in Medical Biotechnology from Universidad de Valladolid, from 2003 to 2005. Antonio furthered their education by completing a PhD in Medical Science, specializing in Molecular Immunology, from 2003 to 2009, also at Universidad de Valladolid.